Insider / Encompass Health Corp
COLTHARP DOUGLAS E
EVP & Chief Financial Officer at Encompass Health Corp
- Company
- Encompass Health Corp
- First filing on record
- October 2, 2025
- Latest trade on record
- October 1, 2026
- SEC filings
- EDGAR ↗
COLTHARP DOUGLAS E, EVP & Chief Financial Officer at Encompass Health Corp, has disclosed 18 transactions in UA, EHC since October 2, 2025: 0 purchases (0 open-market buys) and 7 sales, worth about $11.1M at the reported prices. The latest was filed October 2, 2026, 1 day after the trade; 2 filings were late against the 2-business-day Form 4 deadline.
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
In the last 12 months COLTHARP DOUGLAS E made no purchases and 7 sales worth $8.8M, plus 10 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
COLTHARP DOUGLAS E has traded 1 stock on record; the largest by dollars is EHC.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
2 of 12 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 9 | 118,301 | $1.3M |
| F | Shares withheld for tax | 4 | 32,976 | $3.5M |
| S | Open-market sale | 3 | 46,563 | $5.3M |
| M | Option exercise or conversion | 2 | 55,388 | $912K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 17 | 0 | 7 · $8.8M |
| 2025 | 1 | 0 | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| UA | Other A | October 1, 2026 | October 2, 2026 | 1d | 7,864 | — | — | Form 4 ↗ | ||
| UA | Other A | August 26, 2026 | September 2, 2026 | 7d | 29,880 | — | — | late | Form 4 ↗ | |
| EHC | Sell S | August 10, 2026 | August 11, 2026 | 1d | 18,869 | $125 | $2.4M | Form 4 ↗ | ||
| UA | Other A | July 1, 2026 | July 6, 2026 | 5d | 5,575 | — | — | late | Form 4 ↗ | |
| EHC | Option / conversion M | May 15, 2026 | May 18, 2026 | 3d | 27,694 | — | — | derivative | Form 4 ↗ | |
| EHC | Sell S | May 15, 2026 | May 18, 2026 | 3d | 1 | $107 | $107 | Form 4 ↗ | ||
| EHC | Sell S | May 15, 2026 | May 18, 2026 | 3d | 27,693 | $107 | $3.0M | Form 4 ↗ | ||
| EHC | Option / conversion M | May 15, 2026 | May 18, 2026 | 3d | 27,694 | $33 | $912K | Form 4 ↗ | ||
| UA | Other A | April 1, 2026 | April 2, 2026 | 1d | 6,362 | — | — | Form 4 ↗ | ||
| EHC | Other A | March 2, 2026 | March 3, 2026 | 1d | 12,275 | $108 | $1.3M | derivative | Form 4 ↗ | |
| EHC | Sell F | February 28, 2026 | March 3, 2026 | 3d | 776 | $108 | $84K | Form 4 ↗ | ||
| EHC | Sell F | February 23, 2026 | February 25, 2026 | 2d | 14,818 | $106 | $1.6M | Form 4 ↗ | ||
| EHC | Sell F | February 20, 2026 | February 23, 2026 | 3d | 674 | $107 | $72K | Form 4 ↗ | ||
| EHC | Sell F | February 19, 2026 | February 23, 2026 | 4d | 16,708 | $107 | $1.8M | Form 4 ↗ | ||
| EHC | Other A | February 19, 2026 | February 20, 2026 | 1d | 4,430 | — | — | Form 4 ↗ | ||
| EHC | Other A | February 18, 2026 | February 20, 2026 | 2d | 37,588 | — | — | Form 4 ↗ | ||
| UA | Other A | January 2, 2026 | January 5, 2026 | 3d | 7,027 | — | — | Form 4 ↗ | ||
| UA | Other A | October 1, 2025 | October 2, 2025 | 1d | 7,300 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| October 2, 2026 | Form 4 | 0001336917-26-000143 | 1 | published | EDGAR ↗ |
| September 2, 2026 | Form 4 | 0001336917-26-000125 | 1 | published | EDGAR ↗ |
| August 11, 2026 | Form 4 | 0000785161-26-000192 | 1 | published | EDGAR ↗ |
| July 6, 2026 | Form 4 | 0001336917-26-000088 | 1 | published | EDGAR ↗ |
| May 18, 2026 | Form 4 | 0000785161-26-000158 | 4 | published | EDGAR ↗ |
| April 2, 2026 | Form 4 | 0001336917-26-000046 | 1 | published | EDGAR ↗ |
| March 3, 2026 | Form 4 | 0000785161-26-000083 | 2 | published | EDGAR ↗ |
| February 25, 2026 | Form 4 | 0000785161-26-000071 | 1 | published | EDGAR ↗ |
| February 23, 2026 | Form 4 | 0000785161-26-000053 | 2 | published | EDGAR ↗ |
| February 20, 2026 | Form 4 | 0000785161-26-000043 | 2 | published | EDGAR ↗ |
| January 5, 2026 | Form 4 | 0001336917-26-000002 | 1 | published | EDGAR ↗ |
| October 2, 2025 | Form 4 | 0001336917-25-000177 | 1 | published | EDGAR ↗ |
Other insiders at Encompass Health Corp
- WATSA V PREM ET AL Insider 26 rows
- Tarr Mark J President & CEO 16 rows
- Everson Carolyn Director 12 rows
- Christie Edward M III Director 11 rows
- Darby John Patrick EVP, Gen Counsel & Secretary 11 rows
- Gibbs David W Director 11 rows
- Reidy Christopher R Director 11 rows
- O'Connor Kevin J. SVP & General Counsel 10 rows
- Tuer Patrick William EVP, Chief Operating Officer 9 rows
- Fay Edmund Sr. Vice Pres. and Treasurer 8 rows
Everyone on file, with contracts and lobbying under the company's name: Encompass Health Corp.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 12 | 18 | October 2, 2025 | October 2, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.